# Catheter Ablation Versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF)

> **NCT02755688** · NA · UNKNOWN · sponsor: **Royal Brompton & Harefield NHS Foundation Trust** · enrollment: 120 (actual)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Thoracoscopic Surgical ablation
- **PROCEDURE:** Catheter ablation

## Key facts

- **NCT ID:** NCT02755688
- **Lead sponsor:** Royal Brompton & Harefield NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2019-10-30
- **Final completion:** 2020-03-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-09-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02755688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02755688, "Catheter Ablation Versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02755688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*